Amendment No. 1 to Registration Rights Agreement, dated December 1, 2020, between the Company and the Investors

EX-10.1 4 tm2037225d2_ex10-1.htm EXHIBIT 10.1

 

Exhibit 10.1

 

AMENDMENT NO. 1

TO

REGISTRATION RIGHTS AGREEMENT

 

This Amendment No. 1 to the Registration Rights Agreement (this “Amendment”) is made as of December 1, 2020 and effective as of December 31, 2020, by and among BeiGene, Ltd., a Cayman Islands exempted company (the “Company”) and the undersigned Investors. Capitalized terms used but not otherwise defined herein shall have the meanings given to such terms in the Registration Rights Agreement dated as of November 16, 2016, by and among the Company and the Investors thereto (the “Registration Rights Agreement”).

 

WHEREAS, the Company and the Investors are parties to the Registration Rights Agreement;

 

WHEREAS, in accordance with Section 3.2 of the Registration Rights Agreement, no amendment, alteration or modification of any of the provisions of the Registration Rights Agreement shall be binding unless made in writing and signed by each of the Company and the Investors; and

 

WHEREAS, the Company and the Investors desire to amend the Registration Rights Agreement, effective as of December 31, 2020, as set forth in this Amendment.

 

NOW THEREFORE, for good and valuable consideration, the receipt of which is hereby acknowledged, the Company and the Investors hereby agree as follows:

 

1.Section 2.9 of the Registration Rights Agreement is deleted in its entirety and replaced with:

 

Termination of Status as Registrable Securities. The Registrable Securities shall cease to be Registrable Securities upon the earliest to occur of the following events: (i) such Registrable Securities have been sold pursuant to an effective Registration Statement; (ii) such Registrable Securities have been sold by the Investors pursuant to Rule 144 (or other similar rule), (iii) such Registrable Securities may be resold by the Investor holding such Registrable Securities without limitations as to volume or manner of sale pursuant to Rule 144; or (iv) December 31, 2023.”

 

2.Except to the extent modified herein, the terms and conditions of the Registration Rights Agreement shall remain in full force and effect.

 

3.This Amendment shall be governed by, and construed in accordance with, the law of the State of New York without giving effect to any choice or conflict of law provision or rule (whether of the State of New York or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of New York.

 

4.This Amendment may be executed in any number of counterparts, each of which shall be enforceable against the parties that execute such counterparts (including by facsimile or other electronic means), and all of which together shall constitute one instrument. 

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 

 

 

 

IN WITNESS WHEREOF, the parties hereto have executed this Amendment No. 1 to the Registration Rights Agreement.

 

  COMPANY:
   
  BEIGENE, LTD.
   
  By: /s/ Scott A. Samuels
  Name: Scott A. Samuels
  Title: Senior Vice President, General Counsel

 

 

 

 

IN WITNESS WHEREOF, the parties hereto have executed this Amendment No. 1 to the Registration Rights Agreement.  

 

  INVESTORS:  
   
  667, L.P.
   
  By: BAKER BROS. ADVISORS LP,
    management company and investment adviser to 667, L.P., pursuant to authority granted to it by Baker Biotech Capital, L.P., general partner to 667, L.P., and not as the general partner.
     
  By: /s/ Scott L. Lessing
  Name: Scott L. Lessing
  Title: President
         
  BAKER BROTHERS LIFE SCIENCES, L.P.
     
  By: BAKER BROS. ADVISORS LP,
    management company and investment adviser to Baker Brothers Life Sciences, L.P., pursuant to authority granted to it by Baker Brothers Life Sciences Capital L.P., general partner to Baker Brothers Life Sciences, L.P., and not as the general partner.
     
  By: /s/ Scott L. Lessing
  Name: Scott L. Lessing
  Title: President

 

 

 

 

  14159, L.P.
     
  By:

BAKER BROS. ADVISORS LP,

management company and investment adviser to 14159, L.P., pursuant to authority granted to it by 14159 Capital, L.P., general partner to 14159, L.P., and not as the general partner.

     
  By: /s/ Scott L. Lessing
  Name: Scott L. Lessing
  Title: President

 

 

 

 

IN WITNESS WHEREOF, the parties hereto have executed this Amendment No. 1 to the Registration Rights Agreement.

 

  INVESTORS:  
   
  HILLHOUSE BGN HOLDINGS LIMITED
     
  By: /s/ Colm O’Connell
  Name: Colm O’Connell
  Title: Director

 

  GAOLING FUND, L.P.
     
  By: /s/ Cuifang (Tracy) Ma
  Name: Cuifang (Tracy) Ma
  Title: Authorised Signatory
   
  YHG INVESTMENT, L.P.
     
  By: /s/ Cuifang (Tracy) Ma
  Name: Cuifang (Tracy) Ma
  Title: Authorised Signatory